Who is sponsoring NCT03599115?

NCT03599115 is sponsored by Brigham Young University.

What drugs are being tested in NCT03599115?

Interventions in NCT03599115: Inhibitory Control Training.

What condition does NCT03599115 study?

NCT03599115 studies Overweight and Obesity.

Is NCT03599115 still recruiting?

NCT03599115 is currently completed. Last updated 8 July 2020.

Last reviewed 2020-07-08 · How we verify

NCT03599115: N2ICT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Inhibitory Control Training in Eating Behaviors

Completed NA Last updated 8 July 2020

What this trial tests

NA trial testing Inhibitory Control Training in Overweight and Obesity in 105 participants. Completed in 1 May 2020.

Timeline

26 September 2017

Primary endpoint
1 March 2020

1 May 2020

Quick facts

Lead sponsor	Brigham Young University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	105
Start date	26 September 2017
Primary completion	1 March 2020
Estimated completion	1 May 2020
Sites	1 location across United States

Drugs / interventions tested

Inhibitory Control Training

Conditions studied

Overweight and Obesity — all drugs for Overweight and Obesity →

Sponsor

Brigham Young University

Who can join

Adults 18 to 45, any sex, with Overweight and Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Overweight and obese individuals will be randomly assigned to a food-specific or generic inhibitory control training. Food intake, weight, and neural indices of inhibitory control will be assessed prior, immediately after the 4-week intervention, and 12-weeks after intervention completion to assess the effectiveness of a mobile inhibitory control training intervention over time for health outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Inhibitory Control Training

Trials testing the same drug.

NCT04244032 — Cognitive Enhancement Through Computerized Training · NA · terminated
NCT05041660 — Using Virtual Reality and Sensor Technology to Enhance Outcomes From Treatment for Binge Eating · NA · completed
NCT03438539 — Brief Online Interventions for Alcohol Use · NA · completed

Other recruiting trials for Overweight and Obesity

Currently open trials in the same condition.

NCT06282952 — Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation · NA · recruiting
NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
NCT07230496 — A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healt · Phase 1 · recruiting
NCT07313761 — A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered · Phase 1 · active not recruiting
NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting

Other Brigham Young University trials

Trials by the same sponsor.

NCT06053229 — Effect of Percussive Massage on Skeletal Muscle During Limb Immobilization · NA · recruiting
NCT05902286 — Heart Rate Variability Biofeedback in Older Adults · EARLY_PHASE1 · completed
NCT05913505 — Heart Rate Variability Biofeedback Following Traumatic Brain Injury · EARLY_PHASE1 · unknown
NCT05044715 — Effectiveness of Compassion Focused Therapy (CFT) · NA · terminated
NCT04733287 — Heat Therapy and Muscle Function Study · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03599115 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Brigham Young University
Last refreshed: 8 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03599115.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing